Company Overview of Glaxosmithkline Biologicals S.A.
Glaxosmithkline Biologicals S.A. researches, develops, manufactures, and supplies vaccines. Its vaccination products are used to tackle various diseases, such as rabies, diphtheria, tetanus, and yellow fever, as well as polio, measles, mumps, and rubella and hepatitis B. Glaxosmithkline Biologicals S.A. was formerly known as SmithKline Beecham Biologicals S.A. and changed its name to GlaxoSmithKline Biologicals S.A. in 2000. The company was founded in 1945 and is based in Rixensart, Belgium. Glaxosmithkline Biologicals S.A. operates as a subsidiary of GlaxoSmithKline plc.
Rue de l'institut 89
Founded in 1945
32 2 656 81 11
32 2 656 80 00
Key Executives for Glaxosmithkline Biologicals S.A.
Glaxosmithkline Biologicals S.A. Key Developments
Similar Private Companies By Industry
|S.A. AstraZeneca N.V.||Europe|
|Mylan Belgium BVBA/SPRL||Europe|
|PerkinElmer Life Sciences||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Glaxosmithkline Biologicals S.A., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.